Home » Topics » Medical technology

Medical technology
RSS

Gilead's Integrase Inhibitor Shows Promise In Phase II

March 5, 2007

Relationship Of Targets Predicts Synergy Type For Drug Combos

March 5, 2007

By Anette Breindl

Venture Capital And Other Investments In Private Biotechnology Companies: February 2007

March 5, 2007

Other Financings Of Public Biotechnology Companies: February 2007

March 5, 2007

Public Financing Of Biotechnology: February 2007

March 5, 2007

BioWorld Stock Report For Public Biotechnology Companies

March 5, 2007

Stock Indexes

March 5, 2007

Money Raised By Month

March 5, 2007

Stock Winners and Losers For The Week

March 5, 2007

Money Raised Year To Date

March 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...